GeneQuantum Healthcare Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series C
  • Investors
  • 10

GeneQuantum Healthcare General Information

Description

Developer of bioconjugation drugs. The company's technology uses a ligase dependent conjugation platform that has opened a drastically enlarged therapeutic window, enabling researchers to focus on developing series of anti-tumor Antibody-Drug-Conjugates (ADCs).

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Building D, No.398, Ruoshui Road
  • Suzhou Industrial Park
  • Suzhou, Jiangsu
  • China
+86 0512 0000 0000

GeneQuantum Healthcare Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GeneQuantum Healthcare Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 19-May-2021 000.00 Completed Generating Revenue
3. Later Stage VC (Series B) 19-Nov-2020 000.00 Completed Generating Revenue
2. Later Stage VC 08-May-2019 $14.9M $20.7M Completed Generating Revenue
1. Early Stage VC (Series A) 27-Mar-2017 $5.8M $5.8M Completed Generating Revenue
To view GeneQuantum Healthcare’s complete valuation and funding history, request access »

GeneQuantum Healthcare Executive Team (1)

Name Title Board Seat Contact Info
Gang Qin Ph.D Founder, President, Chief Executive Officer & Chairman
To view GeneQuantum Healthcare’s complete executive team members history, request access »

GeneQuantum Healthcare Board Members (1)

Name Representing Role Since
Gang Qin Ph.D GeneQuantum Healthcare Founder, President, Chief Executive Officer & Chairman 000 0000
To view GeneQuantum Healthcare’s complete board members history, request access »

GeneQuantum Healthcare Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
China Life Private Equity Growth/Expansion Minority 000 0000 000000 0
PICC Capital Investment Management PE/Buyout Minority 000 0000 000000 0
Sunshine Guojian Pharmaceutical Corporation Minority 000 0000 000000 0
BrightGene Bio-Medical Technology Company Corporation Minority 000 0000 000000 0
Win Digital Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »